Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma--a report of eight cases.

AuthorsD Giacchero, J Barrière, K Benezery, B Guillot, C Dutriaux, L Mortier, J P Lacour, A Thyss, F Peyrade
JournalClinical oncology (Royal College of Radiologists (Great Britain)) (Clin Oncol (R Coll Radiol)) Vol. 23 Issue 10 Pg. 716-8 (Dec 2011) ISSN: 1433-2981 [Electronic] England
PMID21831617 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Cetuximab
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy, radiotherapy)
  • Cetuximab
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Skin Neoplasms (drug therapy, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: